Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

News Focus

Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Apr 01, 2024 6:58am

112 Views

Post# 35962284

complete solutions for cardiovascular workflow ACC24 6-8 apr

Ventripoint is now a part of ASCEND Cardiovascular‘s global distribution and marketing for cardiac diagnostic and imaging technologies. Ventripoint’s AI-powered diagnostic technology will be integrated into ASCEND Cardiovascular‘s IT for cardiovascular care for its current user base of over 50,000 hospitals and clinics. The collaboration marks a significant stepping stone for providing access to advanced care for patients and families.

ASCEND will be showcasing its complete solutions for cardiovascular workflow at ACC24 in booth #3701

ASCEND’s Complete Solutions for Enhanced Cardiovascular Workflow:
-Smart Multi-Modality Structured Reporting
-AI-Driven Image Review
-Live Telepresence
-Augmented Reality (AR)
-Open-Schema Data Warehouse and Flexible Analytics

If you are interested in learning more about everything ASCEND has to offer, click the link to schedule a meeting/demo with us!
https://lnkd.in/gws_UeXB

workflowsolutions cardiology medicalai telepresence